L
LTP
LTR PHARMA LIMITED
0.48
-0.01-3.00%Closed16:10 02/20 AEDT
OPEN/PREV CLOSE0.505/0.500
TODAY RANGE0.480-0.505
VOL290.58K
MARKET CAP88.16M
52 WEEK RANGE0.270-0.810
AVG VOL (3M)361.06K
% TURNOVER0.16%
TURNOVER142.82K
P/E (TTM)-14.5210
% RANGE5.00%
EPS(TTM)-0.0334
P/E(FORWARD)--
P/B2.786
BVPS0.174
DIVIDEND--
P/S41.81
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP51.10M
SHARES OUTSTANDING181.78M
NEXT EARNINGS--
FREE FLOAT105.35M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·02/10 01:22
Application for quotation of securities - LTP
ASX·02/01 21:48
SPONTAN Shows Positive Outcomes in Younger Men with ED
ASX·01/27 21:29
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·01/21 21:54
First Patients Dosed in SPONTAN Phase II Clinical Study
ASX·01/21 04:36
Application for quotation of securities - LTP
ASX·01/16 05:59
Notification regarding unquoted securities - LTP
ASX·01/12 21:24
Patient Recruitment Commences for SPONTAN Phase II Study
ASX·01/07 22:15
SPONTAN Phase 1 Study Accepted for WMSM 2026 Podium
ASX·12/22/2025 06:04
Notification regarding unquoted securities - LTP
ASX·12/16/2025 22:13
LTR Pharma Surpasses 1,000 SPONTAN Prescriptions
ASX·12/10/2025 22:46
Application for quotation of securities - LTP
ASX·12/09/2025 22:40
TGA Provides Regulatory Clearance for SPONTAN Phase II
ASX·12/02/2025 22:22
Ethics Approval Received for SPONTAN Phase II Clinical Study
ASX·12/02/2025 04:13
Release of Restricted Securities from ASX Mandatory Escrow
ASX·11/19/2025 22:43
Change of Director's Interest Notice - M McGuire
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others